This session showcases promising new therapies and treatment modalities for neurological disorders currently under investigation. Topics include experimental drugs, biologics, gene therapies, and stem cell-based approaches targeting neurodegenerative diseases, epilepsy, movement disorders, and more. Discussions will cover preclinical and clinical trial data, safety profiles, and efficacy outcomes of emerging therapies. Additionally, regulatory challenges, ethical considerations, and patient perspectives on novel treatments will be explored. The session aims to provide attendees with insights into the pipeline of innovative therapies in neurology, highlighting potential breakthroughs that could transform patient care in the near future.